Current TM picks:
ORCL RBAK CSCO FDRY SCMR IRSN CELN
On the radar:
I'm watching the OLBs hard because rapid consolidation is beginning. Tradescape and MarketXT merged today and SCH and CyberCorp last week. The writing is on the wall.
Special note:
CELN is getting ready to roll again... and it looks like its going to be huge. Worth a look.
My opinions only.
Caio,
TM
***************************************************
Thursday February 10, 8:33 am Eastern Time
Company Press Release
Celsion CEO Interviewed by The Wall Street Reporter
COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 10, 2000--Celsion Corporation (OTC BB:CELN - news) announced today that company president and Chief Executive Officer, Spencer J. Volk, was interviewed this week by The Wall Street Reporter, a real audio, online interview forum. The interview, in which Volk discusses the status of Celsion's various clinical studies, FDA applications, and on-going commercialization phase, is available at the Wall Street Reporter's Web site, located at wallstreetreporter.com.
In the interview, Volk explains the significance of Celsion's breast cancer and benign prostatic hyperplasia (BPH) systems, which are undergoing the clinical trials required for FDA approval. He describes the Company's strategic partnerships with leading universities and medical centers in the United States.
Discussions featured on The Wall Street Reporter are designed to furnish investors with information about viable companies across the marketplace. Statements should not be construed as investment recommendations, or buy/sell advice. These interviews do not constitute paid reports, but rather are an integral part of the Reporter's customer services.
About Celsion Corporation
Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat delivered by patented microwave technology. Clinicals and further development of the Company's treatment systems are being conducted by leading institutions such as Duke University Medical Center, Harbor UCLA Medical Center, Columbia Hospital (a Columbia/HCA Healthcare member), Montefiore Medical Center, Massachusetts Institute of Technology, the University of California at San Francisco, and Duke University.
For more information about Celsion Corporation, visit www.celsion.com.
Forward-looking statements in this release are made pursuant to the ``safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
